Characteristics | Normal sleep 1 (n = 528) | CSD 2 (n = 256) | p or adjusted p (U or χ2) (η2), 1 vs 2 | p or adjusted p (U or χ2) (η2), 3 vs 4 | p or adjusted p (U or χ2) (η2), 5 vs 6 | ||
---|---|---|---|---|---|---|---|
Cognitively normal 3 | Cognitively progressive 4 | Cognitively normal 5 | Cognitively progressive 6 | ||||
Baseline | |||||||
N | 410 | 118 | 160 | 96 | |||
Age (years) | 72.66 ± 6.95 | 75.21 ± 6.74 | 71.73 ± 7.20 | 73.14 ± 6.99 | 0.098 (62,667.0) (0.003) | < 0.001 (18,464.5) (0.029) | 0.167 (6888.0) (0.007) |
Gender (male %) | 47.10 | 44.10 | 51.20 | 59.40 | 0.854 (0.034) (0.007) | 0.564 (0.333) (0.025) | 0.206 (1.596) (0.079) |
Education (years) | 16.65 ± 2.62 | 15.98 ± 2.65 | 15.99 ± 2.62 | 15.98 ± 2.61 | 0.016 (60,552.5) (0.007) | 0.032 (21,101.0) (0.008) | 0.723 (7479.5) (0.000) |
APOE (ε4%) | 42.20 | 56.80 | 37.50 | 60.40 | 0.866 (0.028) (0.002) | 0.005 (7.861) (0.122) | < 0.001 (12.682) (0.223) |
MMSE | 28.69 ± 1.55 | 27.34 ± 1.93 | 28.48 ± 1.57 | 27.64 ± 1.75 | 0.030 (61,286.5) (0.006) | < 0.001 (14,213.5) (0.088) | < 0.001 (5480.0) (0.057) |
ADAS-cog | 12.54 ± 5.80 | 19.33 ± 7.40 | 12.23 ± 5.94 | 18.53 ± 7.53 | 0.315 (64,597.5) (0.001) | < 0.001 (11,618.5) (0.140) | < 0.001 (4001.5) (0.161) |
FAQ | 1.00 ± 2.38 | 3.55 ± 4.49 | 2.03 ± 3.47 | 4.88 ± 5.16 | < 0.001 (48,915.0) (0.050) | < 0.001 (13,948.0) (0.093) | < 0.001 (4728.5) (0.103) |
ADNI-MEM | 0.75 ± 0.69 | − 0.04 ± 0.67 | 0.62 ± 0.72 | 0.03 ± 0.68 | 0.001 (57,652.5) (0.014) | < 0.001 (10,177.5) (0.174) | < 0.001 (4280.0) (0.137) |
MoCA | 25.12 ± 2.92 (n = 335) | 22.15 ± 2.77 (n = 59) | 24.17 ± 3.10 (n = 126) | 21.72 ± 2.93 (n = 58) | < 0.001 (27,283.5) (0.04) | < 0.001 (4464.5) (0.115) | < 0.001 (2095.0) (0.117) |
Blood neutrophil (%) | 60.48 ± 8.02 (n = 373) | 62.00 ± 8.11 (n = 110) | 60.47 ± 8.14 (n = 152) | 64.06 ± 7.71 (n = 85) | 0.850 (53,639.5) (0.003) | 0.325 (18,143.0) (0.007) | 0.010 (4929.0) (0.039) |
CSF AD biomarker | |||||||
N | 405 | 111 | 159 | 96 | |||
Aβ42 (pg/ml) | 1072.77 ± 452.07 | 705.17 ± 309.98 | 1044.35 ± 425.88 | 795.27 ± 395.27 | 1.070 (62,172.5) (0.002) | < 0.001 (11,012.5) (0.132) | < 0.001 (4617.5) (0.109) |
t-tau (pg/ml) | 238.35 ± 97.56 | 332.46 ± 115.14 | 231.89 ± 98.38 | 309.56 ± 123.64 | 0.915 (65,478.0) (0.000) | < 0.001 (11,534.5) (0.120) | < 0.001 (4596.0) (0.111) |
p-tau (pg/ml) | 22.32 ± 11.03 | 33.20 ± 12.84 | 21.71 ± 10.69 | 30.41 ± 14.13 | 1.018 (65,104.0) (0.000) | < 0.001 (10,913.5) (0.134) | < 0.001 (4594.5) (0.111) |
CSF inflammation factor | |||||||
N | 64 | 57 | 32 | 36 | |||
TNFR2 (pg/ml) | 1109.51.88 ± 636.53 | 1054.94 ± 308.02 | 948.15 ± 223.47 | 1091.54 ± 238.77 | 0.731 (3877.5) (0.002) | 1.136 (1802.0) (0.000) | 0.025 (347.0) (0.116) |
TGFβ1 (pg/ml) | 103.05 ± 30.40 | 104.31 ± 51.18 | 91.48 ± 27.43 | 119.11 ± 40.22 | 0.951 (4092.0) (0.000) | 0.927 (1710.5) (0.003) | 0.020 (327.5) (0.137) |
ICAM1 (pg/ml) | 369.10 ± 171.99 | 368.52 ± 166.55 | 310.57 ± 193.74 | 439.62 ± 253.14 | 0.488 (3646.5) (0.009) | 1.019 (1804.0) (0.000) | 0.020 (353.0) (0.110) |
VCAM1 (ng/ml) | 40.57 ± 17.52 | 47.25 ± 29.34 | 32.73 ± 11.53 | 42.30 ± 16.57 | 0.860 (3464.5) (0.017) | 1.267 (1625.0) (0.009) | 0.015 (353.0) (0.110) |
TNFR1 (pg/ml) | 879.43 ± 198.76 | 877.24 ± 253.18 | 800.46 ± 149.88 | 899.37 ± 210.30 | 0.797 (3858.0) (0.003) | 1.006 (1695.0) (0.004) | 0.095 (421.0) (0.053) |
TGFβ2 (pg/ml) | 156.04 ± 48.94 | 157.58 ± 50.13 | 149.73 ± 29.19 | 180.65 ± 57.13 | 0.620 (3637.0) (0.009) | 0.944 (1810.5) (0.000) | 0.052 (395.0) (0.073) |
TGFβ3 (pg/ml) | 9.06 ± 24.88 | 9.46 ± 24.74 | 6.27 ± 19.76 | 11.10 ± 27.89 | 0.824 (3818.0) (0.004) | 0.375 (1482.0) (0.026) | 0.439 (493.0) (0.015) |
IL21 (pg/ml) | 11.71 ± 11.50 | 11.86 ± 10.60 | 13.66 ± 15.37 | 10.69 ± 10.09 | 1.024 (4078.5) (0.000) | 0.854 (1722.5) (0.002) | 1.024 (568.0) (0.000) |
IL7 (pg/ml) | 1.13 ± 1.26 | 1.69 ± 3.22 | 1.18 ± 0.85 | 1.26 ± 1.13 | 1.115 (4065.0) (0.000) | 0.550 (1455.0) (0.030) | 0.922 (568.0) (0.000) |
IL6 (pg/ml) | 5.64 ± 6.55 | 5.17 ± 3.13 | 5.21 ± 6.22 | 4.78 ± 3.89 | 0.770 (3599.0) (0.011) | 1.128 (1679.0) (0.005) | 0.995 (555.0) (0.001) |
Annual rate of change | |||||||
N | 70 | 58 | 33 | 37 | |||
Left hippocampus | 1.02 ± 2.03 | − 1.02 ± 2.52 | 1.60 ± 2.44 | − 1.36 ± 3.15 | 1.402 (4332.0) (0.001) | < 0.001 (1065.0) (0.167) | < 0.001 (266.0) (0.235) |
Right hippocampus | 1.03 ± 3.14 | − 0.68 ± 2.97 | 1.68 ± 4.30 | − 1.73 ± 4.12 | 0.971 (4466.0) (0.000) | 0.001 (1357.0) (0.081) | < 0.001 (291.0) (0.202) |
2-year follow-up | |||||||
N | 319 | 102 | 138 | 87 | |||
MMSE | 28.48 ± 1.92 | 24.91 ± 4.19 | 28.43 ± 1.81 | 25.62 ± 3.25 | 0.038 (42,882.0) (0.006) | < 0.001 (7112.5) (0.174) | < 0.001 (2664.0) (0.219) |
ADAS-cog | 11.95 ± 6.58 | 24.12 ± 11.44 | 11.82 ± 7.11 | 21.75 ± 10.28 | 0.306 (44,618.5) (0.002) | < 0.001 (5560.0) (0.238) | < 0.001 (2608.5) (0.226) |
FAQ | 1.02 ± 2.74 | 8.58 ± 8.16 | 2.50 ± 4.02 | 9.74 ± 8.66 | < 0.001 (32,890.0) (0.057) | < 0.001 (5845.5) (0.226) | < 0.001 (2874.0) (0.192) |
ADNI-MEM | 0.84 ± 0.79 (n = 256) | − 0.36 ± 0.89 (n = 86) | 0.78 ± 0.82 (n = 136) | − 0.23 ± 0.88 (n = 82) | 0.052 (33,646.0) (0.007) | < 0.001 (3550.5) (0.258) | < 0.001 (2155.0) (0.264) |
MoCA | 25.40 ± 3.24 (n = 258) | 20.00 ± 4.33 (n = 49) | 24.78 ± 3.03 (n = 105) | 20.78 ± 4.55 (n = 51) | 0.002 (19,845.5) (0.02) | < 0.001 (1842.0) (0.201) | < 0.001 (1297.0) (0.174) |